1Joseph AP.Economic justification of antimicrobial management programs:Implications of antimicrobial resistance,2000(z2).
2Lucet JC;Decre D;Fichelle A.Control of aprolonged outbreak of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a university hospital[J],1999(06).
3Forrest A;Nix DE;Ballow CH.Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients,1993(05).
4Rahal J J;Urban C;Horn D.Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella[J],1998(14).
5Gonzales R;Malone DC;Maselli JH.Excessive antibiotic use for acute respiratory infections in the United States[J],2001(06).
6McGeer A J;Low DE.Vancomycin-resistant enterococci[J],2000(05).
7Swartz MN.Hospital-aquired infections:disease with increasingly limited therapies,1994(07).
8Thomas JK;Forrest A;Bhavnani SM.Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy[J],1998(03).
